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The regulation of cellular processes by eukaryote-like serine/threonine kinases is widespread in bacteria. In
the last 2 years, several studies have examined the role of serine/threonine kinases in Staphylococcus aureus on
cell wall metabolism, autolysis, and virulence, mostly in S. aureus laboratory isolates in the 8325-4 lineage. In
this study, we showed that the pknB gene (also called stk1) of methicillin-resistant S. aureus (MRSA) strain
COL and the community-acquired MRSA (CA-MRSA) strain USA300 is involved in cell wall metabolism, with
the pknB mutant exhibiting enhanced sensitivity to -lactam antibiotics but not to other classes of antibiotics,
including aminoglycosides, ciprofloxacin, bactrim, and other types of cell wall-active agents (e.g., vancomycin
and bacitracin). Additionally, the pknB mutant of USA300 was found to be more resistant to Triton X-100-
induced autolysis and also to lysis by lysostaphin. We also showed that pknB is a positive regulator of sigB
activity, resulting in compromise in its response to heat and oxidative stresses. In association with reduced sigB
activity, the expression levels of RNAII and RNAIII of agr and the downstream effector hla are upregulated
while spa expression is downmodulated in the pknB mutant compared to the level in the parent. Consistent with
an enhanced agr response in vitro, virulence studies of the pknB mutant of USA300 in a murine cutaneous
model of infection showed that the mutant was more virulent than the parental strain. Collectively, our results
have linked the pknB gene in CA-MRSA to antibiotic resistance, sigB activity, and virulence and have
highlighted important differences in pknB phenotypes (virulence and sigB activity) between laboratory isolates
and the prototypic CA-MRSA strain USA300.
The increasing morbidity and mortality of Staphylococcus
aureus infections are raising concerns (15, 18). A major reason
for this increase is the emergence of community-acquired
methicillin-resistant S. aureus (CA-MRSA) strains that can
affect previously healthy individuals outside the hospital set-
ting. This contrasts with hospital-acquired MRSA (HA-
MRSA) strains, which have been predominantly associated
with immunocompromised hosts in hospitals.
CA-MRSA isolates can be distinguished from their HA-
MRSA counterparts by their enhanced virulence and their
spectrum of resistance to antibiotics. All MRSA strains harbor
chromosomal cassette elements called staphylococcal cassette
chromosome mec (SCCmec) elements, of which there are five
types. CA-MRSA strains possess type IV and occasionally type
V, while the larger types (I to III) are commonly found in
HA-MRSA strains. Within all SCCmec elements is the invari-
ant mecA, which encodes PBP2a and is the principal determi-
nant of methicillin resistance in S. aureus.
Many CA-MRSA strains also carry additional virulence fac-
tors, such as Panton-Valentine leukocidin, and various staph-
ylococcal enterotoxins. However, the role of these toxins in
virulence is still debated. Recent reports have suggested that
the differential expression levels of virulence factors in CA-
MRSA strains may also contribute to the increased pathoge-
nicity of these strains (19, 20).
In eukaryotic cells, many cellular processes are under the
control of serine/threonine kinases. Recent studies have re-
vealed the existence of eukaryotic serine/threonine kinase or-
thologs in bacteria (23). Bacterial homologues of these kinases
have been shown to mediate a diverse range of functions,
including cellular development, regulation, and pathogenesis
(2, 23). The C termini of these kinases can bear three to five
extracellular PASTA (for penicillin-binding protein [PBP] and
serine/threonine kinase-associated) domains, which are peni-
cillin-binding domains analogous to those found in penicillin-
binding proteins while the N termini possess an intracellular
kinase domain (23). Between these two domains is a single
transmembrane segment. It is believed that the extracellular
domain senses and transduces environmental signals by trig-
gering the eukaryote-like N-terminal kinase domain to auto-
phosphorylate and hence activate downstream signaling cas-
cades. The S. aureus genome carries two putative kinase genes,
one of which is pknB (locus SA1063 in S. aureus N315, also
referred to as stk1). Using both laboratory and hospital S.
aureus isolates, several groups have evaluated this gene (5, 9,
24). Despite some strain-to-strain variations in function of
pknB, all three reports implicated that the kinase was involved
in various aspects of cell wall metabolism, such as antibiotic
resistance and autolysis; however, the precise mechanisms con-
trolling these responses remain to be defined. Given the re-
ported differences in antibiotic sensitivities between CA- and
HA-MRSA strains, we sought to determine whether the pknB
kinase gene has a major functional role in CA-MRSA.
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In this report, we demonstrate that pknB of CA-MRSA
strain USA300 is also involved in cell wall metabolism includ-
ing antibiotic resistance. In particular, the pknB mutant was
more sensitive to -lactam antibiotics and became more resis-
tant to the endopeptidase lysostaphin and also to Triton
X-100-induced autolysis. In searching for the mechanism by
which pknB affected antibiotic resistance, we discovered that
the pknB gene was positively involved in controlling the activity
of the alternative sigma factor SigB. Consequently, the pknB
mutant was compromised in its response to heat and oxidative
stresses. As the toxin-expressing phenotype related to agr (e.g.,
alpha toxin) has been shown to be enhanced in a sigB mutant
(7), we also found that the expression levels of regulatory genes
(e.g., sarA and agr) and selected target genes (e.g., hla) were
upregulated in the pknB mutant compared with those in the
parent USA300. The enhanced virulence of the mutant was
also confirmed in a murine cutaneous model of infection. To-
gether, our data suggest that the pknB kinase gene has an
interesting phenotype of enhancing antibiotic resistance and
SigB activity and downregulation of virulence in the most com-
mon CA-MRSA strain, USA300.
MATERIALS AND METHODS
Reagents, bacterial strains, and growth conditions. All reagents were obtained
from either Fisher or Sigma unless specified otherwise. The bacterial strains and
plasmids used in this study are listed in Table 1. S. aureus strains were cultured
on either tryptic soy broth/agar (TSB/A) or Mueller-Hinton broth/agar. Esche-
richia coli strains were cultured on Luria-Bertani medium (LB). Bacterial growth
was monitored at 650 nm, using 18-mm borosilicate glass tubes on a Spectronic
20D spectrophotometer (Spectronic Analytical Instruments, Garforth, En-
gland). Antibiotic selection and plasmid maintenance were provided at the fol-
lowing concentrations: for S. aureus, 2.5 g/ml erythromycin, 10 g/ml chloram-
phenicol, and 75 g/ml kanamycin, and for E. coli, 100 g/ml ampicillin and
carbenicillin and at 34 g/ml chloramphenicol. Xylose was provided at a con-
centration of 0.2% (wt/vol) for gene induction from the heterologous promoter
of pEPSA5 as needed.
DNA manipulations. A list of the oligonucleotides used for strain construction
is available from the authors upon request. Routine cloning procedures were
carried out according to standard laboratory protocols.
A markerless, in-frame deletion of pknB in strains USA300 and COL was
constructed in accordance with a method described previously (23). Briefly, 1-kb
regions flanking the gene of interest were amplified by PCR and joined by
overlap extension. The resulting spliced product was inserted into either pMAD
(COL) or pMAD-Kn (USA300) and transformed first into E. coli DH5, then
into RN4220 for proper methylation, and finally into either COL or USA300.
Successive temperature shifts from 30°C to 42°C were used to promote the
recombination of the pMAD constructs into the chromosome, resulting in the
replacement of the native gene with the spliced allele. Correct clones were
identified by colony PCR and confirmed by sequencing.
The pknB mutant strains were complemented by amplifying the native genes
from either USA300 or COL genomic DNA and inserting them downstream of
the xylose-inducible promoter of the S. aureus expression vector pEPSA5, fol-
lowed by sequence confirmation.
His tag variants of pknB from both USA300 and COL were similarly amplified,
inserted into pET14b, and transformed into E. coli DH5, followed by confir-
mation with PCR and sequencing. For expression, the constructs were trans-
formed into E. coli BL21-DE3.
Antibiotic susceptibility assays. MICs of antibiotics were determined using
Mueller-Hinton broth supplemented with 2% (wt/vol) NaCl, 25 g/ml MgCl2,
and 12.5 g/ml CaCl2 in accordance with the microdilution procedure of the
Clinical and Laboratory Standards Institute (9). Results were scored after 48 h
and reported as modal values for at least 5 independent experiments. Suscepti-
bility to imipenem was determined with the use of filter paper disks impregnated
with 10 g imipenem according to the disk diffusion procedure as outlined by the
manufacturer (Remel). Zones of inhibition were measured after 24 h and re-
ported as average values for 3 independent experiments.
Detection of pknB in whole-cell lysates. E. coli BL21-DE3 cells harboring
pET14b-pknBUSA300 or pET14b-pknBCOL were grown in 2 YT medium to an
optical density at 650 nm (OD650) of 0.3, at which point heterologous protein
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Description Source or reference
S. aureus strains
RN4220 Heavily mutagenized strain that accepts foreign DNA
USA300 Community-acquired MRSA strain
COL Hospital-acquired MRSA strain
ALC6630 USA300 pknB This work
ALC6634 USA300 pknB with pEPSA5 This work
ALC6632 USA300 pknB complemented with pknBUSA300 in pEPSA5 This work
ALC6625 COL pknB This work
ALC6629 COL pknB with pEPSA5 This work
ALC6627 COL pknB complemented with pknBCOL in pEPSA5 This work
ALC6633 USA300 pknB complemented with pknBCOL in pEPSA5 This work
ALC6628 COL pknB complemented with pknBUSA300 in pEPSA5 This work
ALC6635 USA300 pknB with plasmid pALC2109 This work
E. coli strains
XL1-Blue General cloning strain
BL21-DE3 Strain used to express genes driven by the T7 promoter in the pET vector
Plasmids
pMAD E. coli-S. aureus shuttle vector containing a thermosensitive origin of replication,
bgaB; Emr Apr
1
pMAD-Kn pMAD with Knr This work
pEPSA5 E. coli-S. aureus shuttle vector containing a xylose inducible promoter; Apr Cmr 13
pALC2109 pSK236 containing the tetR repressor and the xyl-tetO promoter driving sigB; Cmr 4
pET14b E. coli expression vector to create N-terminal hexahistidine tags, containing an
IPTG inducible T7 promoter; Apr Cmr
pALC6640 pET14b with pknBUSA300 This work
pALC6641 pET14b with pknBCOL This work
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expression was induced by the addition of 0.5 mM IPTG (isopropyl--D-thioga-
lactopyranoside). Equivalent samples of the cultures were taken at the 0-, 2-, and
4-h time points, resuspended in 1 SDS-PAGE sample buffer (containing 62.5
mM Tris-HCl [pH 6.8], 2% SDS, 0.01 mg/ml bromophenol blue, 10% glycerol, 10
mM dithiothreitol [DTT]), boiled for 10 min, resolved on 10% polyacrylamide
SDS-PAGE gels, transferred onto polyvinylidene fluoride (PVDF) membranes
(Millipore), and analyzed according to standard Western blotting procedures.
The primary antibody was mouse anti-His tag antibody (Novagen) used at a
1:5,000 dilution, and the secondary antibody was donkey anti-mouse IgG conju-
gated to horseradish peroxidase (Jackson ImmunoResearch Laboratories, West
Grove, PA) used at a 1:10,000 dilution. The membrane was detected using the
enhanced chemiluminescence (ECL) Western Blot system from GE Healthcare
(Piscataway, NJ).
Autolysis, bacteriolysis, and lysostaphin sensitivity assays. Static autolysis
assays were conducted on exponential phase cells (OD650  0.7). In brief, cells
were cultured in TSB plus 1 M NaCl, harvested, washed twice with ice-cold,
sterile water, resuspended in 50 mM Tris-HCl (pH 7.5) plus 0.05% Triton X-100,
and incubated at 30°C with shaking at 250 rpm, and the optical densities were
serially monitored.
Bacteriolytic assays were performed using heat-killed cells as substrates and
bacterial supernatants as the source of secreted autolysins. Heat-killed cells were
prepared in phosphate-buffered saline (PBS) by heating the bacterial suspension
at 65°C for 2 h and normalized to an OD650 of 5.0. Secreted autolysins in the
culture supernatants were prepared from overnight cultures grown in TSB,
normalized to cells at an OD650 of 10, and sterilized by passage through a 0.2-m
filter. Bacteriolytic activity was assessed by mixing 1 ml of heat-killed cells with
5 ml of supernatant (or TSB as a control) and incubating them at 37°C with
shaking at 250 rpm, and the OD650 monitored. For some experiments, bacteria
were cultured overnight in TSB plus 1 mM phenylmethanesulfonyl fluoride
(PMSF) to inactivate serine proteases in the supernatant.
Lysostaphin sensitivity was assessed by adding lysostaphin (AMBI Products,
LLC, Lawrence, NY) at a final concentration of 1.7 g/ml (for USA300) or 2.5
g/ml (for COL) to late-exponential-phase cells (OD650  1), followed by incu-
bation at 37°C with shaking at 250 rpm. The optical densities of the cultures were
then serially measured.
All data from the autolysis experiments described above are reported as
percentages of the initial turbidity (at the zero time point) and are representative
of 3 independent experiments.
Zymography. Autolysin activity was also visualized on 8% SDS-polyacrylamide
gels containing either heat-killed RN4220 or lyophilized Micrococcus lysodeikti-
cus as described previously (27). Autolysins were extracted from exponential-
phase cells (10 ml at an OD650 of 0.7) with 100 l of 4% SDS, quantitated using
a Pierce bicinchoninic acid (BCA) protein assay kit, applied to the gels, and
resolved electrophoretically. After electrophoresis, the gels were washed exten-
sively in water, incubated in 1% Triton X-100 in 25 mM Tris-HCl (pH 8) for 16 h
at 37°C, and stained with 0.1% methylene blue. Zones of cell lysis were visualized
as clear bands against a blue background. Data shown are representative of three
independent experiments.
Transcriptional analyses. RNA was extracted from approximately 1.2  1011
cells grown to the indicated growth phases using Trizol and a reciprocating
shaker as described previously (26). For quantitative real-time PCR (qRT-PCR)
analysis, the RNA was treated with a DNA-free kit (Ambion) to remove residual
DNA, followed by reverse transcription using a Roche Transcriptor first-strand
synthesis kit. qRT-PCR was performed with Maxima SYBR green qPCR master
mix (Fermentas) in a Roche LightCycler 1.5 system. Absolute and relative
quantification of the resulting amplicons was carried out using LightCycler soft-
ware version 4.0. Data reported are normalized to the gyrB levels.
For Northern blot analysis, RNAs were separated on a 1.5% agarose-0.66 M
formaldehyde gel in 20 mM morpholinepropanesulfonic acid, 10 mM sodium
acetate, 2 mM EDTA (pH 7) and transferred to a Hybond XL membrane as
described previously (23). PCR-generated probes were labeled with -[32P]dCTP
(GE Life Sciences) using a random primed DNA labeling kit (Roche). Following
prehybridization, hybridization with the probe was conducted at 65°C overnight.
The membranes were washed under high-stringency conditions and visualized by
autoradiography. Bands were quantitated with ImageJ as needed. Images shown
are representative of three blots.
Protease assay. Supernatants from 30 ml of overnight cultures in TSB, nor-
malized to an OD650 of 10, were concentrated 150 fold (Centricon; molecular
weight cutoff, 3,000 [Millipore]). After the protein concentration was determined
(BCA assay kit), protease assays of the supernatants were conducted with an
Enz-Chek Bodipy fluorescence kit (Molecular Probes), with the expressed values
standardized to 35 g of total protein in the supernatants.
Stress resistance assays. Temperature sensitivity was assessed by comparing
the growth profiles of cells in TSB at 42°C with shaking at 250 rpm.
Sensitivity to hydrogen peroxide and ethanol was determined by adding these
reagents to exponential-phase cells (OD650  0.7) to give final concentrations of
10 mM and 10% (vol/vol), respectively. Doubling times were calculated by
determining the slope of the curve from 0.7 to 1.4 OD650 units.
Hemolysis assay. Supernatants from overnight cultures grown with normal-
ization to an OD650 of 10 were serially diluted 2-fold in a microtiter plate
containing a suspension of 2% washed rabbit erythrocytes in PBS. The plate was
incubated at 37°C for 1 h, and the hemolytic titers were determined as the
reciprocal of the highest dilution resulting in 50% lysis, using 2% SDS as the
positive control. Reported values are normalized to the protein content of
the supernatants as determined by a Pierce BCA protein assay kit.
Murine model of subcutaneous infection. Early-exponential-phase cells grown
in TSB (OD650  0.35) were harvested, washed, and resuspended in normal
saline to give a final concentration of 108 CFU/ml. The backs of 6-week-old male
C57BL6 mice (Jackson Laboratories, Bar Harbor, ME) were shaved, sterilized
with alcohol wipes, and injected with 100 l of the cell suspension subcutane-
ously. This inoculum was previously determined with a titration assay, resulting
in cutaneous infection in 90% of the mice. The general appearances, lesion sizes,
and weights of the mice were monitored and reported as mean values. Mice were
sacrificed after 3 days, and an 8-mm biopsy punch was made from the lesions. A
portion of the biopsy sample was fixed in 10% formalin for histological analysis
while the remainder was homogenized and used to determine the number of
CFU/gm of tissue. Statistical significance was determined using the Kruskal-
Wallace test, with a P value of 	0.05 considered significant. For histological
analysis, the fixed tissue samples were embedded, cut in 5-m sections, and
stained with hematoxylin and eosin (H&E) according to standard procedures.
Representative sections from each group are shown.
RESULTS
Antibiotic susceptibility of a pknB mutant. The pknB kinase
gene is predicted to encode three extracellular penicillin-bind-
ing domains, called the PASTA domain. We thus speculated
that this protein might be involved in methicillin resistance in
MRSA isolates. To test this hypothesis, a markerless in-frame
deletion of pknB was made in both COL (HA-MRSA) and
USA300 (CA-MRSA) and the antibiotic susceptibilities of
each mutant were compared to those of the parent and com-
plemented mutants (Tables 2 and 3). In both strain back-
grounds, a pknB mutation led to increased susceptibilities to
many -lactams, including the carbapenem imipenem, with the
USA300 pknB mutant being more sensitive to a wider range of
-lactams than the pknB mutant of COL. Provision of pknB in
trans with the plasmid pEPSA5 to both mutant strains resulted
in either a full or a partial restoration of the MIC to wild-type
levels.
Both sets of mutants displayed equivalent susceptibilities to
TABLE 2. Effect of pknB on the susceptibility of Staphylococcus
aureus strain USA300 to -lactam antibioticsa
Antibiotic
MIC for USA300
Wild type pknB pknB/pEPSA5 pknB/pknB
Oxacillin 32 1 0.5 8
Cloxacillin 1 0.125 0.25 2
Penicillin 16 0.25 0.25 16
Carbenicillin 64 1 2 16
Nafcillin 32 1 0.5 16
Ceftriaxone 64 8 8 16
Cephalothin 32 1 0.5 16
Cefazolin 32 0.5 0.5 32
Imipenem 22 37 40 27
a All MICs, with the exception of those for imipenem, are presented in g/ml.
Imipenem sensitivity was measured as zones of clearing in mm.
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representative drugs from other antibiotic classes, including
aminoglycosides, ciprofloxacin, trimethoprim-sulfamethoxazole,
and other cell wall-active agents, such as cycloserine, vancomy-
cin, and bacitracin, compared with their respective parents,
indicating that the antibiotic sensitivity of the pknB mutants
was limited mostly to the -lactam class of antibiotics.
Role of the PASTA domain in antibiotic sensing. Examina-
tion of the pknB genes of USA300 and COL revealed that both
sequences were identical, with the exception of a G-to-T trans-
version at position 1165 in COL. This point mutation translates
into a stop codon, prematurely truncating the kinase protein in
COL (Fig. 1). This region of COL was subsequently rese-
quenced to confirm the transversion.
For expression, the pknB genes from both COL and USA300
were cloned behind the N-terminal His tag of pET14b. After
IPTG induction, the resulting fusion proteins were detected by
Western blot analysis using an anti-His tag antibody (Fig. 1A).
The USA300 pknB construct produced a 72-kDa His tag pro-
tein, in agreement with the predicted size of pknB, while the
His tag PknB protein of COL was only 48 kDa, corresponding
to the truncated size of PknB without the PASTA domains.
Therefore, it appeared that translation of the COL PknB pro-
tein terminated prematurely, as predicted from the G-to-T
transversion.
To determine whether the PASTA domains of pknB made
any contribution to antibiotic resistance, we performed a cross-
complementation experiment. The truncated kinase gene from
COL was provided in trans to the USA300 pknB mutant and
vice versa. Remarkably, both the truncated and full-length
kinase genes were able to complement the pknB mutation in
both strains to equivalent degrees with respect to sensitivity to
-lactams (Fig. 1B), suggesting that the kinase domain alone
TABLE 3. Effect of pknB on the MICs of -lactam
antibiotics against COL
Antibiotic
MIC (g/ml) for COL
Wild type pknB pknB/pEPSA5 pknB/pknB
Oxacillin 256 64 64 256
Cloxacillin 512 2 2 512
Carbenicillin 128 32 32 128
Nafcillin 256 64 64 256
Ceftriaxone 1,024 512 512 1,024
Cephalothin 128 64 64 128
FIG. 1. Structural differences between the PknB kinase proteins of USA300 and COL. (A) Western blot analysis of PknB from USA300 (top
panel) and COL (bottom panel). The pknB gene from each strain was cloned behind an N-terminal His tag. Expression of the fusion proteins after
IPTG induction at 0, 2, and 4 h was monitored by Western blot analysis using a primary antibody directed toward the hexahistidine moiety. The
schematic on the right shows the probable architecture of each PknB kinase protein on the basis of the estimated sizes of each fusion protein. Each
of the PASTA domains is depicted as rectangles, while the kinase domain is represented by an oval. (B) Role of the PASTA domain in antibiotic
resistance. COL and USA300 pknB mutants were complemented and cross-complemented with either their own or the heterologous kinase gene.
The designations pknBu and pknBc correspond to the pkn genes of USA300 and COL, respectively. The antibiotic susceptibilities of the resultant
strains were then compared between the parent and mutant strains by performing MIC assays using nafcillin and cloxacillin.
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was sufficient to restore antibiotic resistance to the pknB mu-
tants. In light of these data, we chose to pursue further work on
pknB in USA300.
Cell wall phenotype of the pknB mutant. Mutants with al-
tered expression of penicillin-binding proteins (PBPs) are fre-
quently sensitive to a range of -lactam antibiotics (21, 22, 24).
Therefore, we speculated that the sensitivity of the pknB mu-
tants to antibiotic may have been due to altered levels of
penicillin-binding proteins. However, Northern blot and real-
time PCR analyses of gene transcription revealed that the
transcript levels of five genes encoding penicillin-binding pro-
teins (mecA, pbp1, pbp2, pbp3, and pbp4) were equivalent in
both the pknB mutant and the USA300 parent strain, suggest-
ing that the antibiotic sensitivity of the pknB kinase mutant was
not due to alterations in pbp transcription. Transmission elec-
tron microscopy also revealed that the cellular morphologies
(i.e., size, cell wall thickness, and septum formation) of all
three strains (parent, mutant, and complemented mutant)
were virtually indistinguishable, supporting the notion that
PBP activity was unaltered in the pknB mutant compared with
that in the parent (data not shown).
We next examined the peptidoglycan cross-bridging of the
pknB mutant by determining its sensitivity to the glycyl-glycine
endopeptidase lysostaphin. Remarkably, the pknB mutant ex-
hibited greater resistance to lysostaphin. After 24 min of lyso-
staphin exposure, only 60% of the pknB cells exhibited lysis
whereas cells of the parent USA300 and complemented strains
were almost completely lysed in an identical time period (Fig.
2A). As the fem genes encode enzymes necessary for the ad-
dition of glycine to the pentaglycine bridge, we analyzed femA
and femB transcription in the pknB mutant by real-time PCR
and found no differences between the mutant and the parent
and the complemented strain, implying that the synthesis of
the glycyl-glycine peptidoglycan cross-bridges was not signifi-
cantly altered in the pknB mutant. Additionally, evaluation of
peptidoglycan cross-linking by high-performance liquid chro-
matography (HPLC) analysis of muropeptides also did not
divulge any significant differences between the parent and the
mutant (data not shown). We thus hypothesized that the pep-
tidoglycan in the pknB mutant may have been cross-linked
aberrantly and hence prevented lysostaphin from recognizing
and/or accessing its substrates.
Autolysis phenotype of the pknB mutant. A lack of gross
morphological changes in the cell wall of the pknB mutant led
us to consider autolysis as an indicator of altered cell wall
metabolism. The pknB mutant exhibited a greater resistance to
autolysis under the static condition, with only 70% of the initial
inoculum lysed after 5 h at 30°C, compared to 90% lysis for
the either the parent or the complemented mutant strain (Fig.
2B). This phenotype was also observed when the bacteria were
cultured for 1 h in the presence of nafcillin prior to the autol-
ysis assay (data not shown).
A comparison of the activities of the secreted autolysins
derived from the parent, mutant, and complemented mutant
disclosed a defect in the ability of the supernatant from the
pknB mutant to lyse cells. After a 6-h incubation period, only
22% of heat-killed USA300 cells were lysed by the pknB su-
pernatant, compared to 63% and 49% by the supernatants of
the parent and the complemented mutant, respectively (Fig.
3A). To determine if there was a defect in the translocation of
autolysins from the cells to the culture supernatants, zymo-
graphic analysis was performed using autolysins prepared from
whole-cell extracts. The autolytic profile of the pknB mutant
displayed a decrease in the activity of the bands corresponding
to the proenzyme of the major autolysin Atl (130 kDa) as well
as the processed Atl (110 kDa) (Fig. 3B). Northern blot anal-
ysis also verified that the transcription of the atl gene was
approximately halved in the pknB mutant in comparison to the
level in the parent and complemented mutant strains (Fig. 4A),
which may account for its reduced autolytic activity. We also
investigated the possibility that the autolysins of the pknB
mutant might be degraded by serine proteases as has previ-
ously been reported (14). Notably, the supernatants derived
from the pknB mutant demonstrated almost twice as much
protease activity than the wild-type or complemented mutant
strains (Fig. 4B), corroborating the evidence for an increase in
the level of transcription of the serine protease operon splA-
splF (Fig. 4A). Inactivation of the bacterial serine proteases
through the addition of PMSF to the culture medium restored
the autolytic activity of the pknB supernatant to wild-type lev-
els (65% and 68% cells lysed, respectively, after 5 h) (Fig. 4C),
thus implicating the role of proteases in reducing the autolytic
activity of the pknB mutant.
Role for pknB in cell stress. Since the pknB mutant did not
exhibit any gross morphological defects in the cell wall that
may have been the underlying cause of its hypersusceptibility
toward -lactams, we next sought alternative explanations for
the observed phenotype. Recent literature has demonstrated
that bactericidal antibiotics, such as -lactams, exert their kill-
ing effects through the production of reactive oxygen species
(29). Thus, we investigated the potential involvement of the
FIG. 2. Cell wall phenotypes of the USA300 pknB mutant. Sensi-
tivity of the pknB mutant to lysostaphin (A) and Triton X-100 (B). The
pknB mutant was complemented with pEPSA5 containing pknB. The
negative control for the mutant is the vector alone.
VOL. 78, 2010 EFFECT OF pknB ON ANTIBIOTIC RESISTANCE AND VIRULENCE 3641
kinase in the stress response by examining the activity of its
primary mediator, the alternative sigma factor SigB, in the
pknB mutant. Quantitative real-time PCR analysis of the SigB-
dependent alkaline shock protein gene asp23 revealed that the
pknB mutant had approximately half the amount of transcript
that the parent and complemented mutant had (Fig. 5A). Cor-
respondingly, the pknB mutant was compromised when it was
grown in the presence of 10 mM hydrogen peroxide or 10%
(vol/vol) ethanol, compared to both the parental strain
USA300 and the complemented mutant (Table 4). The most
dramatic growth defect, however, was observed when the
strains were grown at a temperature of 42°C, with the pknB
mutant severely compromised at the elevated temperature
(Fig. 5B). Remarkably, provision of sigB in trans restored the
growth of the mutant to the wild-type level, confirming that
the growth defect was indeed due to reduced SigB activity in
the pknB mutant (Fig. 5C).
The antibiotic susceptibility of the pknB mutant cross-com-
plemented with sigB was then tested to ascertain whether the
antibiotic sensitivity of the pknB mutant could be attributed to
reduced activity of SigB. The susceptibilities of pknB and its
cross-complemented mutant to -lactams were identical, sug-
gesting that reduced SigB activity was not involved in the
-lactam sensitivity of the mutant (data not shown).
Involvement of pknB in expression of virulence determi-
nants. A number of reports have demonstrated an inverse
relationship between SigB activity and virulence (4, 6, 7, 16,
25). Therefore, we sought to determine whether reduced SigB
expression and augmented protease expression in the pknB
mutant could be linked to a more general virulence phenotype.
Northern blot analyses of several genes linked to the agr reg-
ulatory cascade revealed elevated expression of agr and related
genotypes in the kinase mutant compared to the levels in the
parent. Both RNAII and RNAIII, as well as sarA expression,
were upregulated in the pknB mutant in comparison to the
FIG. 3. Decreased autolysin activity of the pknB mutant. (A) Bac-
teriolytic activities of secreted autolysins in the supernatants of sta-
tionary phase cultures, using heat-killed USA300 cells as the substrate.
(B) Zymographic analysis of autolytic activity of the pknB mutant of
USA300 using either M. lysodeikticus (top panel) or S. aureus 4220
(bottom panel) as the substrate. Note the decrease in the activity of the
proenzyme for major autolysin Atl (130 kDa) and the processed au-
tolysin (110 kDa; arrow) while the activities of the glucosaminidase (55
kDa) and amidase (63 kDa) cleaved from Atl are relatively unchanged.
Numbers underneath the gel panels indicate the relative band inten-
sities as determined by ImageJ.
FIG. 4. Decreased atl transcription and increased protease activity
in the pknB mutant contribute to its autolytic phenotype. (A) Northern
blot analysis of stationary-phase cells showing the transcriptions of atl
and spl (carrying a serine protease operon) in the pknB mutant in
comparison with the levels in the parent and the complemented strain.
(B) Protease activity in the supernatants of stationary-phase cells as
assessed by an Enz-Chek Bodipy fluorescence kit. AU, arbitrary units.
(C) Bacteriolytic activity of supernatants taken from stationary-phase
cultures of different constructs grown in the presence of 1 mM PMSF
using heat-killed USA300 as the substrate.
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levels for the parent and the complemented mutant strain (Fig.
6A). Additionally, the transcription of genes regulated by agr,
such as hla ( hemolysin gene) and spa (protein A gene) in the
mutant was altered in a manner consistent with enhanced agr
expression, displaying upregulation of hla and downregulation
of spa in the mutant compared to the levels for the parent and
the complemented mutant (Fig. 6A). Notably, the pknB mu-
tant demonstrated a 7-fold increase in hemolytic activity com-
pared with the parental strain (Fig. 6B); these data suggest that
the pknB mutant likely possesses a hypervirulent phenotype.
Enhanced virulence of the pknB mutant in a murine cuta-
neous model of infection. To evaluate whether the above-
mentioned regulatory and phenotypic changes bore any clinical
significance, we assessed the virulence of the pknB mutant in a
murine model of cutaneous infection. Twenty-two C57B6 mice
were injected subcutaneously with 100 l of PBS containing
107 CFU (8 mice each with the wild-type and the complement
strains and 6 mice with the mutant). The weights of the mice
were also determined pre- and postinfection as an indicator of
their general health (Fig. 7A). The greatest weight loss was
observed on the first day postinfection, with the mice infected
with the pknB mutant losing on average 1.75 g and the mice in
the wild-type and complement groups losing on average 1.25
g and 1 g, respectively. One day after injection, all of the mice
infected with the pknB mutant developed areas of redness
surrounding the injection sites while inflammation was ob-
served only for 4 of the mice in the wild-type group. By the
second day after infection, all of the mice had developed ery-
thematous cutaneous lesions. The cutaneous lesions of the
mice infected with the pknB mutant were the most severe,
reaching an average diameter of 14.5 mm on the third and
final day of the experiment. The average sizes of the cutaneous
lesions in the mice infected with the parent and complemented
strains were 7.6 mm and 4.5 mm, respectively (Fig. 7B). A
greater number of CFU per gram of tissue was recovered from
the wound sites of the mice in the pknB mutant group (4.5 
107) than from those infected with either the USA300 parent
strain (9.9 106) or the complemented mutant (1.2 106) (Fig.
7C). Histological sections of the wound site stained with H&E
stain from mice infected with the pknB mutant revealed a more
FIG. 5. Decreased SigB activity in the pknB mutant. (A) Real-time
PCR analysis of asp23 transcription in USA300, the pknB mutant, and
the complemented mutant. (B) Growth of the pknB mutant at 42°C in
comparison with that of the parent and complemented strains.
(C) Growth of the pknB mutant complemented with the sigB gene in
trans at 42°C in comparison with that of the parent and the mutant.
TABLE 4. Doubling times of the pknB mutant in 10 mM hydrogen
peroxide and 10% ethanola
Condition
Doubling time (h) for:
USA300 pknB/pEPSA5 pknB/pknB
TSB 1.5 1.9 1.7
H2O2 2.4 3.1 2.4
EtOH 4.6 6.5 4.9
a We defined the doubling time as the time in hours taken to increase the
OD650 from 0.7 to 1.4. EtOH, ethanol.
FIG. 6. Expression of virulence determinants of the pknB mutant.
(A) Northern blot analysis of sarA, RNAIII, RNAII, hla, and spa gene
transcription in USA300, the pknB mutant, and the complemented mu-
tant. (B) Relative hemolytic titers of the pknB mutant with sheep red
blood cells in comparison to those of the parent and complemented
strains.
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severe form of infection than the mice from the other two
groups, as indicated by the greater numbers of bacteria in the
mice infected with the pknB mutant than in those from the
other two groups. In addition, there was a complete loss of
the outer dermal layer and a complete lack of anatomic defi-
nition and cellular structures in the epidermal layer of the mice
infected with the pknB mutant, compared with those seen for
the parent (Fig. 7D).
DISCUSSION
Protein phosphorylation of serine and threonine residues on
effector proteins is a common regulatory event in eukaryotes.
Analyses of an increasing number of bacterial genomes have
divulged eukaryote-like Ser/Thr protein kinase and phos-
phatase genes in prokaryotes (3, 23). In S. aureus, the kinase
gene pknB, lying immediately downstream of the phosphatase
gene stp1, is transcribed together with the phosphatase gene as
an operon (10). Similar to other serine/threonine kinases in
Gram-positive bacteria, the PknB protein of S. aureus has
three domains, including an amino-terminal kinase domain, a
transmembrane segment, and three PASTA domains at the C
terminus. However, in analyzing the pknB genes of strains
USA300 and COL, we found that the PknB protein in strain
USA300 is intact while its counterpart in COL is truncated due
to a G-to-T transversion at position 1165, leading to a prema-
ture stop codon and hence lacking the PASTA domains (Fig.
1). Western blot analysis indeed confirmed that the His tag
PknB protein in strain COL is 48 kDa, much smaller than the
full-length His tag PknB protein of USA300 (at 72 kDa). As
the PASTA domain has previously been linked to the binding
of -lactams (2, 30), we proceeded to determine the sensitivity
of the pknB mutant of USA300 to these antibiotics. Similar to
what has been found with N315 (5), the pknB mutants of
strains USA300 and COL, representing CA- and HA-MRSA,
respectively, were more sensitive to an assortment of -lactam
antibiotics, including a carbapenem (i.e., imipenem), than the
respective parents. Interestingly, there were no differences in
sensitivity to other cell wall-active agents, including vancomy-
cin, cycloserine, and bacitracin, between the pknB mutant and
the corresponding parent, thus implying restricted sensitivity to
common -lactams and carbapenem and not to other cell wall-
active agents.
Prior studies suggested that the PASTA domain may sense
the presence of -lactam antibiotics, leading to activation of
the kinase domain (30). However, despite not having any of the
PASTA domains, the pknB gene of COL was able to restore
the MICs of the pknB mutant of USA300 for nafcillin and
cloxacillin to parental levels in cross-complementation exper-
iments (Fig. 1B). Given that PknB proteins can autophosphor-
ylate (5), this finding implied that the sensing of -lactam by
the PASTA domain and the ensuing activation of the kinase
domain may be more intricate than previously thought.
Despite the sensitivity of the pknB mutant of USA300 to
-lactam, we did not observe any gross morphological cell wall
changes in the mutant on transmission electron microscopy,
nor did we discern any significant changes in cross-linking in
the HPLC analysis of muropeptides in the mutant, compared
FIG. 7. Ability of the pknB mutant to cause murine skin infections. Six-week-old C57BL6 mice were injected with USA300, the pknB mutant,
or the complemented strain. Weight changes during the course of the experiment were noted (A). After 3 days, the mice were sacrificed and their
skin lesions were examined for size (B), bacterial burden (C), and histological changes in punch biopsy samples (D). In panels B and C, an asterisk
represents P values of 	0.05 as determined by the Kruskal-Wallace test. (D) Note the absence of the dermis and other subcellular structures ()
and the presence of bacteria (3) in the sample taken from the mouse infected with the pknB mutant.
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with what was observed for the parent (data not shown). How-
ever, subtle changes in the peptidoglycan cross-bridge likely
occur because the pknB mutant exhibited increased resistance
to lysis by lysostaphin, a glycyl-glycine endopeptidase targeting
the pentaglycine cross-bridge between peptidoglycan strands.
Besides resistance to lysostaphin-mediated lysis, the pknB mu-
tant of USA300 also displayed greater resistance to autolysis in
0.05% Triton X-100 under static conditions at 30°C when au-
tolysins are still active while cell wall synthesis is slowing down.
The effect of pknB on resistance to autolysis in strain USA300
may be 2-fold. First, the transcription of atl, the major autol-
ysin gene, was decreased in the mutant compared to the level
in the parent. This effect of pknB on atl was supported by
recent microarray studies by Donat et al., demonstrating that
atl and lytM expression is reduced in the pknB mutant of 8325
while transcription of lytR and lgrA, which are repressors of
autolysis, is elevated (12). Second, the effect of autolysin may
be decreased due to enhanced serine protease activity in the
mutant (Fig. 4B). The latter observation was corroborated by
the restoration of autolytic activity of the pknB mutant upon
the addition of PMSF to the culture medium.
Perturbations in cell wall metabolism represent a unique
form of cell stress. For this reason, we explored if pknB mod-
ulates the activity of SigB, a transcription factor intimately
involved in the stress response of S. aureus. Analysis of the
SigB-dependent alkaline shock protein gene asp23 revealed
decreased sigB activity in the pknB mutant, but this activity was
restored in the complemented mutant. Consistent with the
defect in SigB activity were the slower growth at the elevated
temperature (42°C) and the longer generation times of the
mutant upon exposure to 10 mM hydrogen peroxide or 10%
ethanol than of the parent. These findings are also in concor-
dance with the observation by Truong-Bolduc et al. in which
they proposed that additional factors related to sigB and pknB
may contribute to the regulatory effect of MgrA on the expres-
sion of the norA promoter (28). At this junction, we do not
know whether the effect of pknB on SigB is direct or indirect.
Whether PknB phosphorylates an antisigma factor, such as
RsbU, is not known. Nevertheless, the linkage between PknB
and stress response may provide a pathway whereby PknB
contributes toward pathogenesis.
In previous studies, it has been shown that sigB mutants
exhibit an enhanced agr response (7, 16, 17, 25). To confirm
this phenotype in the pknB mutant, we assayed for RNAII and
RNAIII expression and the downstream effector genes. As
expected from an enhanced agr phenotype, the expression lev-
els of RNAII, RNAIII, and hla were elevated in the pknB
mutant compared with the levels in the parent while spa ex-
pression was downmodulated. The increased expression of
proteolytic activity in the pknB mutant was also consistent with
an elevated agr response.
On the basis of increased agr expression, we hypothesized
that the pknB mutant may be more virulent than the parental
strain USA300. A murine model of cutaneous infection has
confirmed our hypothesis. Notably, our findings are in stark
contrast to the studies by Débarbouillé et al., who showed that
the kinase mutant of strain SH1000 had reduced survival in the
kidney in a murine bacteremic pyelonephritis model (10). The
discrepancy between our studies and theirs could be due to
several factors: (i) USA300 is a clinical CA-MRSA isolate
whereas SH1000 is a laboratory strain, (ii) ours was a murine
subcutaneous model while theirs was a bacteremic model look-
ing at kidney abscesses, and (iii) data from Truong-Bolduc et
al. indicated that additional factors related to sigB and pknB
may contribute to the regulatory effect of virulence determi-
nants (28).
On the basis of the above observations on USA300, we have
proposed a model (Fig. 8) whereby the PknB protein regulates
SigB activity and also stress resistance. Activation of SigB
would downregulate agr and its effector genes, including hla
and splA-splF, leading to reduced virulence of S. aureus. Ad-
ditionally, the reduced effect of protease on Atl in a pknB
strain may promote normal autolysis in a growing S. aureus
cell. Besides agr, it also appears that PknB positively regulates
sarA transcription. It has been known that SarA can downregu-
late its own promoter (8). Moreover, recent studies by Didier
et al. have described the phosphorylation of SarA by PknB
(11). Whether phosphorylated SarA binds differently to the
sarA promoter compared to its unphosphorylated counterpart
is not known. The above-mentioned scenarios, coupled with
the finding that SarA is also a positive regulator on agr, implied
that the effect of PknB on target genes such as hla and spa is
complex and may involve a combination of factors, including
SarA and agr. The relationship among PknB, SarA, and agr
with respect to virulence, autolysis, stress response, and anti-
biotic resistance in community-acquired strains of S. aureus is
currently under investigation in our laboratory.
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